BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ebrahimi N, Adelian S, Shakerian S, Afshinpour M, Chaleshtori SR, Rostami N, Hamblin MR, Aref AR. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.006] [Reference Citation Analysis]
2 Dillard C, Borde C, Mohammad A, Puchois V, Jourdren L, Larsen AK, Sabbah M, Maréchal V, Escargueil AE, Pramil E. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine. Int J Mol Sci 2021;22:11472. [PMID: 34768902 DOI: 10.3390/ijms222111472] [Reference Citation Analysis]
3 Liu X, Yin L, Shen S, Hou Y. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.09.006] [Reference Citation Analysis]
4 Ding G, An J, Li L. MicroRNA-103a-3p enhances sepsis-induced acute kidney injury via targeting CXCL12. Bioengineered 2022;13:10288-98. [PMID: 35510354 DOI: 10.1080/21655979.2022.2062195] [Reference Citation Analysis]
5 Mehla K, Hollingsworth MA. Inflammatory and immune effects on tumor progression. Trends Immunol 2021:S1471-4906(21)00258-1. [PMID: 34953686 DOI: 10.1016/j.it.2021.11.009] [Reference Citation Analysis]
6 Ozel I, Duerig I, Domnich M, Lang S, Pylaeva E, Jablonska J. The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. Cancers 2022;14:536. [DOI: 10.3390/cancers14030536] [Reference Citation Analysis]
7 Afify SM, Hassan G, Seno A, Seno M. Cancer-inducing niche: the force of chronic inflammation. Br J Cancer 2022. [PMID: 35292758 DOI: 10.1038/s41416-022-01775-w] [Reference Citation Analysis]
8 Zheng C, Zhang W, Wang J, Zhai Y, Xiong F, Cai Y, Gong X, Zhu B, Zhu HH, Wang H, Li Y, Zhang P. Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.021] [Reference Citation Analysis]
9 Desai S, Dharavath B, Manavalan S, Rane A, Redhu AK, Sunder R, Butle A, Mishra R, Joshi A, Togar T, Apte S, Bala P, Chandrani P, Chopra S, Bashyam MD, Banerjee A, Prabhash K, Nair S, Dutt A. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 2022;4:zcac006. [PMID: 35252868 DOI: 10.1093/narcan/zcac006] [Reference Citation Analysis]
10 Eptaminitaki GC, Wolff N, Stellas D, Sifakis K, Baritaki S. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy. Cells 2021;10:3313. [PMID: 34943820 DOI: 10.3390/cells10123313] [Reference Citation Analysis]
11 Sherwani MA, Abdelgawad A, Chung M, Ibrahim S, Eraslan M, Elmets CA, Yusuf N. Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice. Cancers (Basel) 2021;13:5406. [PMID: 34771569 DOI: 10.3390/cancers13215406] [Reference Citation Analysis]
12 Zhang J, Lai Y, Zhu L, Lu Z, Hu C, Zhou H, Lu Z, Tang Z, He Z, Tang F, Tharmalingam J. A Novel Inflammation-Related Gene Signature for Overall Survival Prediction and Comprehensive Analysis in Pediatric Patients with Wilms Tumor. Disease Markers 2022;2022:1-17. [DOI: 10.1155/2022/2651105] [Reference Citation Analysis]
13 Huang Y, Wang J, Huang J, Tang L, Xu Y, Sun H, Tang J, Wang G. Pyroptosis, a target for cancer treatment? Apoptosis. [DOI: 10.1007/s10495-021-01703-y] [Reference Citation Analysis]
14 Arévalo B, Blázquez-garcía M, Valverde A, Serafín V, Montero-calle A, Solís-fernández G, Barderas R, Yáñez-sedeño P, Campuzano S, Pingarrón J. Simultaneous electrochemical immunosensing of relevant cytokines to diagnose and track cancer and autoimmune diseases. Bioelectrochemistry 2022. [DOI: 10.1016/j.bioelechem.2022.108157] [Reference Citation Analysis]
15 Bergandi L, Apprato G, Silvagno F. Antioxidant and Anti-Inflammatory Activity of Combined Phycocyanin and Palmitoylethanolamide in Human Lung and Prostate Epithelial Cells. Antioxidants 2022;11:201. [DOI: 10.3390/antiox11020201] [Reference Citation Analysis]
16 Wetzel A, Bonnefoy F, Chagué C, Vetter M, Couturier M, Baffert B, Adotévi O, Saas P, Perruche S. Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells. Front Immunol 2022;12:812171. [DOI: 10.3389/fimmu.2021.812171] [Reference Citation Analysis]
17 Tan K, Naylor MJ. Tumour Microenvironment-Immune Cell Interactions Influencing Breast Cancer Heterogeneity and Disease Progression. Front Oncol 2022;12:876451. [DOI: 10.3389/fonc.2022.876451] [Reference Citation Analysis]
18 Olbei M, Thomas JP, Hautefort I, Treveil A, Bohar B, Madgwick M, Gul L, Csabai L, Modos D, Korcsmaros T. CytokineLink: A Cytokine Communication Map to Analyse Immune Responses-Case Studies in Inflammatory Bowel Disease and COVID-19. Cells 2021;10:2242. [PMID: 34571891 DOI: 10.3390/cells10092242] [Reference Citation Analysis]
19 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
20 Lee SY, Lee DY, Kang JH, Kim JH, Jeong JW, Kim HW, Oh DH, Yoon SH, Hur SJ. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention. Food Research International 2022;156:111327. [DOI: 10.1016/j.foodres.2022.111327] [Reference Citation Analysis]
21 Barca C, Foray C, Hermann S, Herrlinger U, Remory I, Laoui D, Schäfers M, Grauer OM, Zinnhardt B, Jacobs AH. The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke). Front Immunol 2021;12:787307. [PMID: 34950148 DOI: 10.3389/fimmu.2021.787307] [Reference Citation Analysis]
22 Parodi A, Kostyushev D, Brezgin S, Kostyusheva A, Borodina T, Akasov R, Frolova A, Chulanov V, Zamyatnin AA. Biomimetic approaches for targeting tumor inflammation. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.007] [Reference Citation Analysis]
23 Milošević N, Rütter M, David A. Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines. Front Med Technol 2022;4:846065. [DOI: 10.3389/fmedt.2022.846065] [Reference Citation Analysis]
24 Attah EI, Ugwuagbo SC, Chinnam S, Eze FI, Nnadi CO, Agbo MO, Obonga W, Rudrapal M, Walode SG, Nizam A, Sahoo RK, Bendale AR, Khairnar SJ, Jagtap MR. Anti-inflammatory activity of Sabicea brevipes Wernharm (Rubiaceae). PHAR 2022;69:311-7. [DOI: 10.3897/pharmacia.69.e82311] [Reference Citation Analysis]
25 Hassan G, Ohara T, Afify SM, Kumon K, Zahra MH, Fu X, Al Kadi M, Seno A, Salomon DS, Seno M. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-021-02167-3] [Reference Citation Analysis]
26 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
27 Li YT, Wu HL, Liu CJ. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1. Int J Mol Sci 2021;22:9380. [PMID: 34502289 DOI: 10.3390/ijms22179380] [Reference Citation Analysis]
28 Raza S, Rajak S, Tewari A, Gupta P, Chattopadhyay N, Sinha RA, Chakravarti B. Multifaceted role of chemokines in solid tumors: From biology to therapy. Semin Cancer Biol 2022:S1044-579X(21)00304-7. [PMID: 34979274 DOI: 10.1016/j.semcancer.2021.12.011] [Reference Citation Analysis]
29 Zhang H, Zhao B, Wei H, Zeng H, Sheng D, Zhang Y. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer. J Ethnopharmacol 2021;287:114915. [PMID: 34954267 DOI: 10.1016/j.jep.2021.114915] [Reference Citation Analysis]
30 Hu T, Pan M, Yin Y, Wang C, Cui Y, Wang Q. The Regulatory Network of Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway in Viral Evasion. Front Microbiol 2021;12:790714. [PMID: 34966372 DOI: 10.3389/fmicb.2021.790714] [Reference Citation Analysis]
31 Zhao S, Zhang X, Chen S, Zhang S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discov 2021;7:283. [PMID: 34635646 DOI: 10.1038/s41420-021-00678-8] [Reference Citation Analysis]
32 Anil SM, Peeri H, Koltai H. Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action. Front Pharmacol 2022;13:908198. [DOI: 10.3389/fphar.2022.908198] [Reference Citation Analysis]
33 Zhao X, Yu M, Zhao Y, Zheng Y, Meng L, Du K, Xie Z, Lv H, Zhang W, Liu J, Wang Q, Yuan Y, Wang Z, Deng J. Circulating cell-free mtDNA release is associated with the activation of cGAS-STING pathway and inflammation in mitochondrial diseases. J Neurol 2022. [PMID: 35486214 DOI: 10.1007/s00415-022-11146-3] [Reference Citation Analysis]
34 Pan Y, Wang T, Zhao Z, Wei W, Yang X, Wang X, Xin W. Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation. JIR 2022;Volume 15:557-71. [DOI: 10.2147/jir.s338162] [Reference Citation Analysis]
35 Zhu J, Huang R, Yang R, Xiao Y, Yan J, Zheng C, Xiao W, Huang C, Wang Y. Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration. Cancer Cell Int 2021;21:529. [PMID: 34641869 DOI: 10.1186/s12935-021-02223-0] [Reference Citation Analysis]
36 Akesolo O, Buey B, Beltrán-visiedo M, Giraldos D, Marzo I, Latorre E. Toll-like receptors: new targets for multiple myeloma treatment? Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.114992] [Reference Citation Analysis]
37 Impellizzeri D, Fusco R, Genovese T, Cordaro M, D’amico R, Trovato Salinaro A, Ontario ML, Modafferi S, Cuzzocrea S, Di Paola R, Calabrese V, Siracusa R. Coriolus Versicolor Downregulates TLR4/NF-κB Signaling Cascade in Dinitrobenzenesulfonic Acid-Treated Mice: A Possible Mechanism for the Anti-Colitis Effect. Antioxidants 2022;11:406. [DOI: 10.3390/antiox11020406] [Reference Citation Analysis]
38 Wang H, Man Q, Huo F, Gao X, Lin H, Li S, Wang J, Su F, Cai, L, Shi Y, Liu, B, Bu L. STAT3 pathway in cancers: Past, present, and future. MedComm 2022;3. [DOI: 10.1002/mco2.124] [Reference Citation Analysis]
39 de Oliveira Zanuso B, de Oliveira Dos Santos AR, Miola VFB, Gissoni Campos LM, Spilla CSG, Barbalho SM. Panax ginseng and aging related disorders: A systematic review. Exp Gerontol 2022;161:111731. [PMID: 35143871 DOI: 10.1016/j.exger.2022.111731] [Reference Citation Analysis]
40 Praveen TK, Gangadharappa HV, Abu Lila AS, Moin A, Mehmood K, Krishna KL, Hussain T, Alafanan A, Shakil S, Rizvi SMD. Inflammation targeted nanomedicines: patents and applications in cancer therapy. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.004] [Reference Citation Analysis]
41 Gao X, Li Y, Ma Z, Jing J, Zhang Z, Liu Y, Ding Z. Obesity induces morphological and functional changes in female reproductive system through increases in NF-κB and MAPK signaling in mice. Reprod Biol Endocrinol 2021;19:148. [PMID: 34560886 DOI: 10.1186/s12958-021-00833-x] [Reference Citation Analysis]
42 Mehrabadi AZ, Ranjbar R, Farzanehpour M, Shahriary A, Dorostkar R, Hamidinejad MA, Ghaleh HEG. Therapeutic potential of CAR T cell in malignancies: A scoping review. Biomed Pharmacother 2021;146:112512. [PMID: 34894519 DOI: 10.1016/j.biopha.2021.112512] [Reference Citation Analysis]
43 Sprooten J, Vankerckhoven A, Vanmeerbeek I, Borras DM, Berckmans Y, Wouters R, Laureano RS, Baert T, Boon L, Landolfo C, Testa AC, Fischerova D, Van Holsbeke C, Bourne T, Chiappa V, Froyman W, Schols D, Agostinis P, Timmerman D, Tejpar S, Vergote I, Coosemans A, Garg AD. Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer. J Immunother Cancer 2021;9:e003609. [PMID: 34795003 DOI: 10.1136/jitc-2021-003609] [Reference Citation Analysis]
44 Liu W, Liu T, Cao A, Qin S, Feng J, Zhang X. Coordination between anti-inflammation and antitumor actions for systematic tumor treatments with improved prognosis. Chemical Engineering Journal 2022;439:135711. [DOI: 10.1016/j.cej.2022.135711] [Reference Citation Analysis]
45 Simon Davis DA, Atmosukarto II, Garrett J, Gosling K, Syed FM, Quah BJ. Irradiation immunity interactions. J Med Imaging Radiat Oncol 2022. [PMID: 35261190 DOI: 10.1111/1754-9485.13399] [Reference Citation Analysis]
46 Peng B, Nguyen TM, Jayasinghe MK, Gao C, Pham TT, Vu LT, Yeo EYM, Yap G, Wang L, Goh BC, Tam WL, Luo D, Le MT. Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy. J of Extracellular Vesicle 2022;11. [DOI: 10.1002/jev2.12187] [Reference Citation Analysis]
47 Ouyang M, Yu C, Deng X, Zhang Y, Zhang X, Duan F. O-GlcNAcylation and Its Role in Cancer-Associated Inflammation. Front Immunol 2022;13:861559. [DOI: 10.3389/fimmu.2022.861559] [Reference Citation Analysis]
48 Jha NK, Arfin S, Jha SK, Kar R, Dey A, Gundamaraju R, Ashraf GM, Gupta PK, Dhanasekaran S, Abomughaid MM, Das SS, Singh SK, Dua K, Roychoudhury S, Kumar D, Ruokolainen J, Ojha S, Kesari KK. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling. Semin Cancer Biol 2022:S1044-579X(22)00049-9. [PMID: 35218902 DOI: 10.1016/j.semcancer.2022.02.022] [Reference Citation Analysis]
49 Krapež G, Kouter K, Jovčevska I, Videtič Paska A. Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles. Biomedicines 2022;10:151. [DOI: 10.3390/biomedicines10010151] [Reference Citation Analysis]